Mineralys Therapeutics, Inc. Stock Performance
as on September 22, 2026 at 4:09 am IST
Day's Low
Day's High
$27.94$28.44
0.68%
Downside
1.10%
Upside
52 Week's Low
52 Week's High
$22.30$47.6520.73%
Downside
69.39%
Upside
Mineralys Therapeutics, Inc. share price movements today
- Previous Close
- $28.02
- Open
- $28.19
- Volume
- 347.1K
- Market Cap
- $2.5B
- Day's Low - High
- $27.94 - $28.44
- 52 Week Low - High
- $22.30 - $47.65
Mineralys Therapeutics, Inc. Historical Returns
- 1 Month Return
- + 9.24 %
- 3 Month Return
- + 13.76 %
- 1 Year Return
- -28.65 %
- 3 Year Return
- + 161.38 %
- 5 Year Return
- 0 %
Mineralys Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Mineralys Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.5B
EPS (TTM)
-4.24
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-6.61
Industry PE ratio
-13.56
PEG Ratio
0.059608620995955985
EBITDA
-349.5M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-57.97%
Mineralys Therapeutics, Inc. Stock Valuation
Track how Mineralys Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Mineralys Therapeutics, Inc. in the last 5 years
Lowest (-15.85x)
December 31, 2025
Today (-15.85x)
December 31, 2025
Industry (-13.56x)
December 31, 2025
Highest (-3.20x)
December 31, 2022
Today’s Price to Earnings Ratio: -15.85x
Mineralys Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Mineralys Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $2.5B | NA | -6.61 | 0.00% | 0.00% | |
| Neutral | $61.5B | -64.51% | -19.3 | -12.57% | 0.00% | |
| StrongBuy | $130.1B | 174.21% | 29.81 | 86.04% | 0.00% | |
| Buy | $80.8B | 21.32% | 18.48 | 84.86% | 0.47% |
Stock Returns calculator for Mineralys Therapeutics, Inc. Stock including INR - Dollar returns
The Mineralys Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Mineralys Therapeutics, Inc. investment value today
Current value as on today
₹77,718
Returns
Returns from Mineralys Therapeutics, Inc. Stock
Dollar Impact
₹6,086 (+6.09%)
Analyst Recommendation on Mineralys Therapeutics, Inc. Stock
Based on 6 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Mineralys Therapeutics, Inc.. Average target price of $48.5
Mineralys Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Mineralys Therapeutics, Inc..
What analysts predicted
42%UPSIDE
Target Price
$48.5
Current Price
$28.13
Analyzed by
6 Analysts
Target
$48.50
Mineralys Therapeutics, Inc. target price $48.5, a slight upside of 42% compared to current price of $28.13. According to 6 analysts rating.
Indian Investors' Interest in Mineralys Therapeutics, Inc. Stock
Search interest for Mineralys Therapeutics, Inc. Stock has increased by 30% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:30% versus previous 30 day period
Mineralys Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Mineralys Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Mineralys Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Mineralys Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Mineralys Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, MLYS stock has moved up by 9.2%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, MLYS has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 538.9%
About Mineralys Therapeutics, Inc.
| Organisation | Mineralys Therapeutics, Inc. |
| Headquarters | 150 N. Radnor Chester Rd., Radnor, PA, 19087, US |
| Industry | Biotechnology |
| CEO | Jon Congleton |
| E-voting on shares | Click here to vote |
Key Management of Mineralys Therapeutics, Inc.
Name | Title |
|---|---|
Dr. Robert McKean Ph.D. | Senior Vice President of CMC |
Mr. Eric J. Warren R.Ph. | Chief Commercial Officer |
Mr. Michael Tortorici Ph.D., Pharm.D. | Senior Vice President of Translational Medicine |
Dr. Jon Congleton | President, CEO & Director |
Dr. Brian Taylor Slingsby M.D., M.P.H., Ph.D. | Founder & Executive Director |
Mr. Adam Scott Levy | CFO & Secretary |
Mr. Jeffrey A. Munsie J.D. | Chief Legal Officer |
Ms. Danielle Mahoney | Senior Vice President of Quality Assurance |
Ms. Jessica Ibbitson | Executive Vice President of Operations |
Dr. James J. Ferguson III, FACC, M.D. | Chief Medical Officer |
FAQs
What is Mineralys Therapeutics, Inc. share price today?
Mineralys Therapeutics, Inc. share price today is $28.13 as on . Mineralys Therapeutics, Inc. share today touched a day high of $28.44 and a low of $27.94.
What is the 52 week high and 52 week low for Mineralys Therapeutics, Inc. share?
Mineralys Therapeutics, Inc. share touched a 52 week high of $47.65 on and a 52 week low of $22.30 on . Mineralys Therapeutics, Inc. stock price today i.e. is trending at $28.13,which is 40.97% down from its 52 week high and 26.14% up from its 52 week low.
What is Mineralys Therapeutics, Inc.'s market capitalisation today?
Mineralys Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Mineralys Therapeutics, Inc. Stock (MLYS) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Mineralys Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Mineralys Therapeutics, Inc. Shares that will get you 0.0533 shares as per Mineralys Therapeutics, Inc. share price of $28.13 per share as on September 21, 2026 at 10:39 pm IST.
What is the minimum amount required to buy Mineralys Therapeutics, Inc. Stock (MLYS) from India?
Indian investors can start investing in Mineralys Therapeutics, Inc. (MLYS) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in Mineralys Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Mineralys Therapeutics, Inc. share’s latest price of $28.13 as on September 21, 2026 at 10:39 pm IST, you will get 0.3555 shares of Mineralys Therapeutics, Inc.. Learn more about
fractional shares .